These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Severity of local inflammation does not impact development of fibrosis in mouse models of intestinal fibrosis. Hünerwadel A; Fagagnini S; Rogler G; Lutz C; Jaeger SU; Mamie C; Weder B; Ruiz PA; Hausmann M Sci Rep; 2018 Oct; 8(1):15182. PubMed ID: 30315190 [TBL] [Abstract][Full Text] [Related]
3. Treatment of Intestinal Fibrosis in Experimental Inflammatory Bowel Disease by the Pleiotropic Actions of a Local Rho Kinase Inhibitor. Holvoet T; Devriese S; Castermans K; Boland S; Leysen D; Vandewynckel YP; Devisscher L; Van den Bossche L; Van Welden S; Dullaers M; Vandenbroucke RE; De Rycke R; Geboes K; Bourin A; Defert O; Hindryckx P; De Vos M; Laukens D Gastroenterology; 2017 Oct; 153(4):1054-1067. PubMed ID: 28642198 [TBL] [Abstract][Full Text] [Related]
4. Caveolin-1 Alleviates Crohn's Disease-induced Intestinal Fibrosis by Inhibiting Fibroblasts Autophagy Through Modulating Sequestosome 1. Yu M; Zhu W; Wang J; Chen X; He X; Lin B; Cen L; Zhou T; Lu C; Yu C; Sun J Inflamm Bowel Dis; 2022 Jun; 28(6):923-935. PubMed ID: 35020883 [TBL] [Abstract][Full Text] [Related]
9. Anti-MMP-9 Antibody: A Promising Therapeutic Strategy for Treatment of Inflammatory Bowel Disease Complications with Fibrosis. Goffin L; Fagagnini S; Vicari A; Mamie C; Melhem H; Weder B; Lutz C; Lang S; Scharl M; Rogler G; Chvatchko Y; Hausmann M Inflamm Bowel Dis; 2016 Sep; 22(9):2041-57. PubMed ID: 27542125 [TBL] [Abstract][Full Text] [Related]
10. Anti-fibrotic Drugs for Crohn's Disease: Ready for Prime Time? Argollo M; Gilardi D; Roda G; Fiorino G; Peyrin-Biroulet L; Danese S Curr Pharm Des; 2019; 25(1):47-56. PubMed ID: 30848192 [TBL] [Abstract][Full Text] [Related]
11. The Oxysterol Synthesising Enzyme CH25H Contributes to the Development of Intestinal Fibrosis. Raselli T; Wyss A; Gonzalez Alvarado MN; Weder B; Mamie C; Spalinger MR; Van Haaften WT; Dijkstra G; Sailer AW; Imenez Silva PH; Wagner CA; Tosevski V; Leibl S; Scharl M; Rogler G; Hausmann M; Misselwitz B J Crohns Colitis; 2019 Sep; 13(9):1186-1200. PubMed ID: 31220227 [TBL] [Abstract][Full Text] [Related]
12. P2X7 Receptor Regulates Collagen Expression in Human Intestinal Fibroblasts: Relevance in Intestinal Fibrosis. Lis-López L; Bauset C; Seco-Cervera M; Macias-Ceja D; Navarro F; Álvarez Á; Esplugues JV; Calatayud S; Barrachina MD; Ortiz-Masià D; Cosín-Roger J Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629116 [TBL] [Abstract][Full Text] [Related]
13. Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin. Mathur R; Alam MM; Zhao XF; Huang Y; Zhu X J Vis Exp; 2019 Sep; (151):. PubMed ID: 31566603 [TBL] [Abstract][Full Text] [Related]
14. Elafin Reverses Intestinal Fibrosis by Inhibiting Cathepsin S-Mediated Protease-Activated Receptor 2. Xie Y; Fontenot L; Chupina Estrada A; Nelson B; Wang J; Shih DQ; Ho W; Mattai SA; Rieder F; Jensen DD; Bunnett NW; Koon HW Cell Mol Gastroenterol Hepatol; 2022; 14(4):841-876. PubMed ID: 35840034 [TBL] [Abstract][Full Text] [Related]
16. Nickel particles are present in Crohn's disease tissue and exacerbate intestinal inflammation in IBD susceptible mice. Matsuda H; Nibe-Shirakihara Y; Tamura A; Aonuma E; Arakawa S; Otsubo K; Nemoto Y; Nagaishi T; Tsuchiya K; Shimizu S; Ma A; Watanabe M; Uo M; Okamoto R; Oshima S Biochem Biophys Res Commun; 2022 Feb; 592():74-80. PubMed ID: 35032835 [TBL] [Abstract][Full Text] [Related]
17. Pathogenic aspects and therapeutic avenues of intestinal fibrosis in Crohn's disease. Zorzi F; Calabrese E; Monteleone G Clin Sci (Lond); 2015 Dec; 129(12):1107-13. PubMed ID: 26494636 [TBL] [Abstract][Full Text] [Related]
18. Total flavone of Abelmoschus manihot regulates autophagy through the AMPK/mTOR signaling pathway to treat intestinal fibrosis in Crohn's disease. Zhang D; Liu J; Lv L; Chen X; Qian Y; Zhao P; Zhang Q; Chen Y; Qian H J Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38803139 [TBL] [Abstract][Full Text] [Related]
19. Pirfenidone prevents radiation-induced intestinal fibrosis in rats by inhibiting fibroblast proliferation and differentiation and suppressing the TGF-β1/Smad/CTGF signaling pathway. Sun YW; Zhang YY; Ke XJ; Wu XJ; Chen ZF; Chi P Eur J Pharmacol; 2018 Mar; 822():199-206. PubMed ID: 29374548 [TBL] [Abstract][Full Text] [Related]